Celyad Oncology SA (CLYYF)
Celyad Oncology Market Cap : 11.19M for April 29, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Galapagos NV | 1.836B |
| UCB SA | 50.00B |
| Ion Beam Applications SA | 467.14M |
| Fagron NV | 1.943B |
| AgomAb Therapeutics NV | 528.92M |
Market Cap Related Metrics
| PE Ratio | 8.361 |
| PS Ratio | 440.73 |
| Price to Book Value | 0.4806 |
| Price | 0.25 |
| Earnings Yield | 11.96% |
| Normalized PE Ratio | 8.361 |